5:57 PM
 | 
Nov 28, 2012
 |  BC Extra  |  Company News

EC approves linaclotide

The European Commission approved Constella linaclotide from Almirall S.A. (Madrid:ALM) and partner Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) to treat moderate to severe irritable bowel...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >